# Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

> **NCT00766870** · PHASE2 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 35 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Lu AA34893
- **DRUG:** Venlafaxine extended release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00766870
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Study was previously paused and is now terminated
- **Last updated:** 2010-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766870, "Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00766870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*